Stay updated on METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis

Sign up to get notified when there's something new on the METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis page.
Latest website image capture
Clouds background image

Latest updates to the METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:26:12.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the progression-free survival (PFS) data for patients with microsatellite-stable (MSS)/mismatch repair-proficient (pMMR) metastatic colorectal cancer (mCRC) undergoing sequential treatment with the Nordic FLOX regimen and nivolumab compared to standard-of-care therapy.
    Difference
    0.1%
    Check dated 2024-06-06T14:38:54.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change includes examples of eligibility criteria such as a person's general health condition or prior treatments.
    Difference
    37%
    Check dated 2024-05-22T20:54:50.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-04-30T22:24:52.000Z thumbnail image

Stay in the know with updates to METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis

Enter your email address, and we'll notify you when there's something new on the METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis page.